RIMBARLAT 

Rimbarlat is a pharmacological product that accelerates sports muscle injuries regenerative process

OWNER

Jorge Martin Cordero (See Profile)


Sector

Biotech

Stage

In vitro, proof of concept

Country

Spain


EXPECTED MARKET ENTRY FOR 2024-2025 SPORTS SEASONS

SPORTS MUSCLE INJURIES ARE A MARKET NICHE: THERE ARE NO PRODUCTS AVAILABLE IN THE MARKET FOR MUSCLE REGENERATION

OUR PRODUCT HAS A STRONG SCIENTIFIC BACKGROUND AND IS BACKED UP FOR A HUGE AMOUNT OF SCIENTIFIC PAPERS

Status

–

IP Type

Trade secret

Time

–

Countries

Coverage

Trade secret encompass both technical information such as concerning research, pharmaceutical test data, manufacturing process and commercial information,, such as distribution methods, list of suppliers and clients, and advertising strategies.

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 26th of November

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar